Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.

by Justin P Williams, Inki Kim, Emma Ito, Wei Shi, Shijun Yue, Lillian L Siu, John Waldron, Brian O'Sullivan, Kenneth W Yip, Fei-Fei Liu
Published 2014-01-01

Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer.

by Michelle Lenarduzzi, Angela B Y Hui, Shijun Yue, Emma Ito, Wei Shi, Justin Williams, Jeff Bruce, Noriko Sakemura-Nakatsugawa, Wei Xu, Aaron Schimmer, Fei-Fei Liu
Published 2013-01-01